The Harvard researchers began by analysing the three - dimensional structure of the small region of the nerve cell sheath protein that is
targeted by immune cells in MS patients.
Not exact matches
By dissecting the heritage of these
cells, we can find new
targets to tackle a range of conditions including infectious diseases, cancers and
immune disorders, and even make vaccines more effective.»
Although the group didn't identify the toxin's
target, it probably causes
cells to die from within
by overstimulating the
immune system, says immunologist Harry Hill of the University of Utah.
Researchers at Penn State have combined the two approaches
by taking biodegradable polymer nanoparticles encapsulated with cancer - fighting drugs and incorporating them into
immune cells to create a smart,
targeted system to attack cancers of specific types.
One potential way that the penile microbiome can increase HIV risk is
by triggering production of
immune factors that lure HIV
target cells to the penis.
Joseph Wu of Stanford University, California, and his team have found that a mouse's
immune system can be primed to recognise and
target cancer
cells by vaccinating them beforehand with stem
cells.
«When mosquitoes are infected with these viruses, there's a signal that lets the mosquito's
cells know that they are infected, resulting in
targeting of the virus
by the mosquito's
immune response.
This is characterised
by the
targeted strengthening of the body's own
immune cells, unlike in chemotherapy, in which the aim is direct destruction of the cancer
cells.
By manipulating the function of certain
immune cells, called T
cells, researchers could help restore the system's balance and create new treatments to
target these diseases.
Particularly prominent in the RNA - Seq analysis was the up - regulation of a number of granzymes, a group of proteinases secreted
by immune cells that were originally thought to be involved in killing (via apoptosis) virus infected
cells or other
target cells.
As with innate immunity, the adaptive
immune system — the T
cells and antibodies produced
by B
cells that
target specific molecules on invading
cells — contributes to pathology or may also fight against it.
In laboratory studies, daratumumab caused the
targeted killing of CD38 - carrying tumor
cells by several distinct and potent mechanisms, including some that involve the
immune system.
The researchers are now planning to address the impact of
targeting autophagy either clinically and pharmacologically on the
immune landscape of melanomas
by phenotyping other
immune cells in the melanoma tumor microenvironment.
«This remodeling process of the
cell proteome
by autophagy is an important
immune - suppressive survival mechanism for Ras - driven cancers, and inhibiting autophagy can provide a means to
target these aggressive cancers,» notes White, who is also a distinguished professor of molecular biology and biochemistry at Rutgers School of Arts and Sciences.
Most
cells from a foreign donor, such as in transplanted organs, are
targeted by the
immune system, but «this one has found a way to suppress the
immune system of its hosts long enough to let it be passed along,» he says.
Because previous work in rats and monkeys has found that proteins that block the costimulatory signal can hold T
cells at bay, Kim Olthoff, a transplant surgeon at the University of Pennsylvania Medical Center in Philadelphia, thought her team could achieve a
targeted immune suppression
by getting the transplanted organ itself — rather than proteins injected into the bloodstream — to block the costimulatory signal.
When the scientists blocked Treg
cells from accumulating in the fat
by targeting a molecule that the
immune cells require, mice no longer developed type 4 diabetes in old age.
An international research team headed
by the rheumatologist Dr Andreas Ramming at Friedrich - Alexander - Universität Erlangen - Nürnberg (FAU) has now managed to identify an
immune system
cell type that can be used in a
targeted attempt to control the inflammatory response in arthritis patients.
Two types of vaccines were used for the study: one constructed with genetically engineered DNA molecules that teach
immune system
cells to recognize premalignant
cells expressing HPV16 E7 proteins, and one that is a non-infectious, engineered virus that
targets and kills precancerous
cells marked
by HPV16 and HPV18 E6 and E7 proteins.
Moffitt researchers wanted to determine if it would be possible to activate the cancer - fighting properties of T
cells indirectly
by targeting another type of
immune cell called a dendritic
cell.
Antibodies only bind to
target cells Peptide antibodies developed
by Kwak and co-discoverer, Hong Qin, Ph.D., assistant professor of Lymphoma / Myeloma, wipe out MDSCs in the blood, spleen and tumor
cells of mice without binding to other white blood
cells or dendritic
cells involved in
immune response.
Scientists have found a way to
target elusive
cells that suppress
immune response, depleting them with peptides that spare other important
cells and shrink tumors in preclinical experiments, according to a paper published online
by Nature Medicine.
«Our results suggest that heart failure would be better addressed
by treatments that shut down
immune cells that are both sources and
targets of cytokines in the spleen and heart, instead of
targeting any one cytokine,» said Sumanth Prabhu, M.D., director of the Division of Cardiovascular Disease within the UAB School of Medicine and study leader.
Certain molecules on tumors can serve as
targets for attack
by cells of the
immune system.
«This is because the stress led to poor function against the cancer
by T -
cells, which are very important in the
immune system's control and surveillance of tumours and are a major
target in many immunotherapy treatments.»
A new study shows that a 70 - year - old malaria drug can block
immune cells in the liver so nanoparticles can arrive at their intended tumor site, overcoming a significant hurdle of
targeted drug delivery, according to a team of researchers led
by Houston Methodist.
«Brain cancer
cells are very good at evading the host
immune system, because they do not express specific
targets that can be recognized
by immune cells,» said Liau, professor and vice chair of neurosurgery.
In the new paper, researchers led
by Dr. Torres showed that LPA keeps T
cells inactivated even after they have «seen» a
target, or antigen, on a cancer
cell that would normally trigger an
immune response.
By targeting CTLA - 4, ipilimumab restimulates the
immune system to
target tumor
cells.
Neoantigens are molecules on
cell's surfaces that are produced
by DNA mutations that are present in cancer
cells but not in normal
cells, making neoantigens ideal
targets for
immune therapy against cancer, say the scientists.
The authors noted: «From this perspective,
by strengthening tumor - associated
immune responses,
targeting [regulatory T
cell] autophagy could act in synergy with strategies that block autophagy in tumor
cells for added benefits in cancer therapy.»
Regardless of the
targeted organ for
cell replacement or regeneration, the shared challenges in
cell therapies for diabetes such as transplant procedure and
immune rejection will be well - served
by the collective expertise within CCTD.
Although, Hedrick and Linden
target different
cell types, innovations
by both groups could encourage clinical tests of drugs designed to switch on a patient's
immune cells by eradicating secondary lung malignancies.
In future research supported
by the National Institutes of Health, the researchers will study exactly how mucosal fibroblasts make
immune cells more «infectable», which could ultimately lead to new
targets for preventing HIV.
With their deep expertise in the biology of senescent
cells, the Campisi lab will be focused on fundamental research into questions like how senescent
cells vary in their susceptibility and resistance to
immune clearance (depending on factors like their tissues of residence or the pathway that led them into senescence); the
targets and mechanisms used
by NK
cells to clear senescent
cells; and why subsets of senescent
cells might persist when their similarly - situated neighbors are cleared out (and what might allow us to overcome that resistance).
There is already evidence that senescent
cells are
targeted by the innate
immune system.
By engineering an artificial protein that
targets the product of such potentially cancer - causing gene fusions, Hur hopes to trigger
immune defense mechanisms that kill rogue
cells harboring the fusions.
They presented frontline research in various fields such as large - scale methods to identify novel drug
targets, how to extract more information from microscopic images
by the use of computational methods, as well as the movement and behavior of
immune cells.
These «surface proteins» are easily recognized
by the
immune cells and
targeted for destruction.
The
target of «atezo» is a molecule called PD - L1, which some cancer
cells make to try to avoid being killed
by the
immune system.
Adoptive
Cell Transfer (ACT) is a form of immunotherapy that
targets tumors specifically and potently
by utilizing large numbers of a patient's own
immune cells to
target and destroy cancer
cells.
The approach developed
by the MGH team starts with the engineered protein, which in this case fuses an antibody fragment
targeting a protein called mesothelin — expressed on the surface of such tumors as mesothelioma, ovarian cancer and pancreatic cancer — to a protein from the tuberculosis bacteria that stimulates the activity of dendritic and other
immune cells.
Sophisticated
cell targeting systems such as the gene therapy approach developed for senescent
cell clearance
by Oisin Biotechnologies could also be turned to stem
cell or
immune cell destruction, given suitable markers of
cell chemistry.
In preclinical research, tumor
cells lysed
by coxsackievirus A21 (CVA21), a naturally occurring «common cold» ICAM - 1 —
targeted RNA virus, induced a secondary systemic host - generated antitumor
immune response.
• Disease - driving pathways that involve the human
immune system are often
targeted by antibodies, and Organ - Chips recreate complex interactions of different human
cell types and aspects of the human
immune system, overcoming limitations of animal models which do not reflect all human
immune cells.
It is Dr. Chou's hope that,
by treating colon cancer stem
cells with DAC and then exposing them to
immune cells that have been primed to recognize NY - ESO - 1, he can generate a
targeted and durable
immune response against these
cells without harming healthy
cells.
«
By bringing our research together, we want to illuminate pathways by which tumor cells and HIV evolve to avoid immune system attacks and use this knowledge to identify new targets for prevention and treatment for both diseases.&raqu
By bringing our research together, we want to illuminate pathways
by which tumor cells and HIV evolve to avoid immune system attacks and use this knowledge to identify new targets for prevention and treatment for both diseases.&raqu
by which tumor
cells and HIV evolve to avoid
immune system attacks and use this knowledge to identify new
targets for prevention and treatment for both diseases.»
In order to help identify them as
targets that should be attacked
by the
immune cells, antibodies bind to these foreign
cells.